Brazil’s Oncoclínicas to test market with US$666 milion IPO

The company controlled by Goldman Sachs funds may debut on B3 valued between R$11 (US$2.09) billion and R$15 billion.

RIO DE JANEIRO, BRAZIL - Oncoclínicas has decided to go to the market with an initial public offering (IPO). The company's base offer should reach R$3.5 billion (US$666 million), lower than the company's initial intention when it planned to list its shares on the B3 exchange.

The value represents the amount of the operation with no additional and supplementary lots,  which considers the midpoint of the price range suggested per share ranging from R$22.21 to R$30.29.

The operation could reach a maximum of R$4.8 billion were it to come . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?